These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 31968657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities.
    Bashmail HA, Alamoudi AA, Noorwali A, Hegazy GA, AJabnoor G, Choudhry H, Al-Abd AM.
    Sci Rep; 2018 Aug 03; 8(1):11674. PubMed ID: 30076320
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.
    Arafa el-SA, Zhu Q, Shah ZI, Wani G, Barakat BM, Racoma I, El-Mahdy MA, Wani AA.
    Mutat Res; 2011 Jan 10; 706(1-2):28-35. PubMed ID: 21040738
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
    Adinew GM, Messeha SS, Taka E, Badisa RB, Antonie LM, Soliman KFA.
    Nutrients; 2022 May 19; 14(10):. PubMed ID: 35631261
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Elemene Injection Overcomes Paclitaxel Resistance in Breast Cancer through AR/RUNX1 Signal: Network Pharmacology and Experimental Validation.
    Gu X, Xu L, Fu Y, Fan S, Huang T, Yu J, Chen J, Sui X, Xie X.
    Curr Pharm Des; 2024 May 19; 30(29):2313-2324. PubMed ID: 38918989
    [Abstract] [Full Text] [Related]

  • 16. YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells.
    Yang YF, Lee YC, Wang YY, Wang CH, Hou MF, Yuan SF.
    Kaohsiung J Med Sci; 2019 Jul 19; 35(7):408-416. PubMed ID: 31001932
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1.
    Li J, Khan MA, Wei C, Cheng J, Chen H, Yang L, Ijaz I, Fu J.
    Molecules; 2017 Dec 04; 22(12):. PubMed ID: 29207526
    [Abstract] [Full Text] [Related]

  • 20. Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models.
    Foglietta F, Spagnoli GC, Muraro MG, Ballestri M, Guerrini A, Ferroni C, Aluigi A, Sotgiu G, Varchi G.
    Int J Nanomedicine; 2018 Dec 04; 13():4847-4867. PubMed ID: 30214193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.